Comparative Pharmacology
Head-to-head clinical analysis: FLEXERIL versus RALDESY.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FLEXERIL versus RALDESY.
FLEXERIL vs RALDESY
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Cyclobenzaprine is a centrally acting muscle relaxant that acts primarily at the brainstem, reducing tonic somatic motor activity via inhibition of descending serotonergic pathways. It is structurally related to tricyclic antidepressants and exhibits anticholinergic, sedative, and analgesic effects.
Selective beta-3 adrenergic receptor agonist; relaxes detrusor smooth muscle during storage phase of urinary bladder fill cycle, increasing bladder capacity and reducing urgency.
10 mg to 15 mg orally three times a day; maximum daily dose: 30 mg.
Intravenous: 1 mg/kg every 8 hours; maximum single dose 100 mg.
None Documented
None Documented
Terminal elimination half-life is 18 hours (range 8–37 hours) with clinical context: requires dose adjustment in hepatic impairment; steady-state reached in ~3–5 days.
4-6 hours in adults; prolonged to 8-12 hours in elderly or renal impairment (CrCl <30 mL/min)
Primarily hepatic; approximately 50% excreted in urine as metabolites, less than 1% unchanged; 40% excreted in feces via bile.
Primarily renal (85-90%) with 60% unchanged; biliary/fecal (10-15%)
Category C
Category C
Muscle Relaxant
Muscle Relaxant